Could medical cannabis help with MS, Parkinson’s, epilepsy or nerve pain? We explore what the research shows and where questions remain… Go to Source Author:

This week, the Cannabis Health Symposium came to Germany for the first time, bringing healthcare professionals, researchers, policymakers and industry operators to Mainhaus in Frankfurt on Wednesday, 4 November. Coming […] Go to Source Author:

If you stroll through major European cities like Berlin, Madrid, or Amsterdam or walk down high streets in London and Manchester, you will notice a massive shift in how people […] Go to Source Author:

BvCW president Dirk Heitepriem will speak in Frankfurt today about how lessons from across Europe could improve medical cannabis prescribing and patient care in Germany. Go to Source Author:

Joining us on Wednesday 4 November? Here is your guide to everything you need to know… Go to Source Author:

Lessons from medical cannabis markets across Europe will be explored at this week’s Cannabis Health Symposium in Frankfurt, with a focus on improving prescribing and patient care in Germany. Go to Source Author:

Endometriosis affects an estimated 190 million people worldwide, and gaps in care are leading to an increased interest in cannabis-based medicines. What do we know about how these might help, and does the science support it? Go to Source Author:

Copeia co-founder Garvin Hirt will join researchers in Frankfurt to discuss how politicians and doctors should make cannabis decisions when evidence is incomplete. Go to Source Author:

Has online prescribing improved medical cannabis care in Germany? Bertan Türemis will join a Frankfurt debate on telemedicine, prescribing standards and patient safety. Go to Source Author:

Canify’s Silvia von Pistor will join a discussion on medicine quality and what happens when patients need to switch products. Go to Source Author:

Pain specialist Dr Michael Überall discusses cannabinoid-based medicines, opioids, and what meaningful improvement looks like for patients. Go to Source Author:

Dr Sue Clenton explores the growing interest and potential of cannabinoid-based therapies to address unmet needs in women’s health. Go to Source Author:

Pharmacist Nitin Makadia will discuss safer prescribing and lessons from European medical cannabis care at Frankfurt’s symposium on 4 November. Go to Source Author:

Ahead of Frankfurt’s Cannabis Health Symposium, Professor Bernd Werse discusses changing cannabis use and the evidence policymakers still need. Go to Source Author:

Lisa Katharina Haag will bring her perspective on cannabis policy and patient care to the one-day event. Go to Source Author:

Nicole Farah reflects on how much we’re still learning about the relationship between hormones, the endocannabinoid system (ECS) and cannabis-based medicines. Go to Source Author:

Dr Julian Wichmann will discuss patient assessments, follow-up care and responsibility for treatment. Go to Source Author:

Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU. Yet, the current federal government’s Ministry […] Go to Source Author:

Professor Bernd Werse will join a debate examining the evidence behind cannabis policy on 4 November. Go to Source Author:

The pharmaceutical industry representative will examine treatment costs and what policy changes mean for patients. Go to Source Author:

Researchers in Scotland are testing CBD for endometriosis and the lasting effects of chemotherapy, while European back-pain trials have helped bring a cannabis medicine to market. Cannabis Health looks at the studies, their findings and what comes next. Go to Source Author:

Professor Sylvia Mechsner will examine the evidence for medical cannabis in women’s health on 4 November. Go to Source Author:

The European Medicinal Cannabis Association’s general secretary will join a debate on how research informs cannabis policy in less than two weeks time. Go to Source Author:

Families of patients with treatment-resistant epilepsy in the UK have received confirmation from a UK drug manufacturer that a six-month supply of Bedrolite is available. In an email sent to […] Go to Source Author:

Changes to Germany’s health insurance rules have left patients facing new limits on funded cannabis treatment. Cannabis Health explains the rules and the industry’s objections. Go to Source Author:

Doctors, pharmacists and researchers will meet in Frankfurt on 4 November to discuss changes affecting medical cannabis treatment. With two weeks to go, here’s what’s on the programme and how to book… Go to Source Author:

Ahead of the Cannabis Health Symposium Frankfurt next month, Dr Shabnam Sarshar discusses the growing demand for medical cannabis among women, the gaps in clinical evidence, and why female-specific research is urgently needed. Go to Source Author:

Plans for greater scrutiny and monitoring have been broadly welcomed, but some patients fear a “knee-jerk” reaction and say cannabis is not the “whole story”. Go to Source Author:

Online services have made medical cannabis easier to get hold of in Germany – but are patients getting the medical checks they need? Would tighter rules make prescribing safer or just leave patients struggling to find a doctor and get their medicine? Cannabis Health explores the [...]

More women are exploring medical cannabis to manage symptoms such as sleep disturbances, anxiety, and chronic pain during the menopause. Go to Source Author:

Campaigner Lara Smith is bringing patients together to challenge a “cruel” system she says leaves them struggling to afford “life-changing” treatment. Go to Source Author:

In this bi-weekly series, Dr Sue Clenton explores the growing interest and potential of cannabis-based therapies to address unmet needs in women’s health conditions. Go to Source Author:

A researcher specialising in the social and cultural factors that shape health and medicine has been announced as a speaker at a medical cannabis conference in London next month. Go to Source Author:

The endocannabinoid system (ECS) plays an important role in bodily function. Here, we unpack the science that is often missing from medical school curricula. Go to Source Author:

The Cannabis Health Symposium Frankfurt will bring together experts from across Germany’s medical cannabis sector. Here’s what to expect from every session. Go to Source Author:

A pharmaceutical executive leading work on international cannabis standards will speak at medical cannabis conferences in Frankfurt and London this autumn. Go to Source Author:

A former Frankfurt drugs official will examine how stigma around cannabis can affect patients receiving it as a medical treatment at a conference in the city next month. Go to Source Author:

The association between cannabis and psychosis is among the most studied — and most contested — areas of cannabinoid medicine. Go to Source Author:

Whether cannabinoid medicines could offer a better overall treatment option than opioids for some people with chronic pain will be examined at a medical cannabis conference in Frankfurt this November. Go to Source Author:

What is actually legal when it comes to medical cannabis in the UK? From prescriptions and possession to driving, smoking and NHS access, here’s what patients need to know about the law in 2026. Go to Source Author:

The director of the UK’s only World Anti-Doping Agency-accredited laboratory has been announced as a speaker at a medical cannabis conference in London next month. Go to Source Author:

Curaleaf Laboratories and Vericura announce a new UK medical cannabis manufacturing and distribution agreement. Go to Source Author:

This autumn, a number of events across the UK and Europe will put conversations about women’s health centre stage. Go to Source Author:

A data and economics specialist working across Germany’s medical cannabis sector will join the Cannabis Health Symposium Frankfurt later this year. Go to Source Author:

A senior figure behind one of Germany’s medical cannabis telemedicine platforms has been announced as a speaker at an event hosted by Cannabis Health later this year. Go to Source Author:

How do medical cannabis vaporisers work, what are the different types, and what should UK patients know about using them safely? Go to Source Author:

Officials are working on more definitive guidelines around driving and medical cannabis ahead of Cannabis Health Symposium later this year. Go to Source Author:

Anxiety is one of the most common conditions for which medical cannabis is prescribed in the UK, but the evidence base remains mixed. Go to Source Author:

The flagship London event relocates to Woolwich Works after record demand, with two further European events to be revealed over the coming weeks Go to Source Author:

Denmark’s medicines regulator found no new safety concerns linked to medical cannabis in 2025 – despite the number of patients receiving prescriptions rising by more than half. Go to Source Author: